Mayo Clinic Laboratories in Rochester, Minn., today will begin testing for monkeypox, the Centers for Disease Control and Prevention announced. Health care providers can order the test from Mayo Clinic Laboratories just as they would other tests, with results reported to jurisdictions as outlined in CDC’s reporting guidance. The laboratory will use CDC’s orthopoxvirus test and anticipates it can handle up to 10,000 tests per week.

“This will not only increase testing capacity but also make it more convenient for providers and patients to access tests by using existing provider-to-laboratory networks,” said CDC Director Rochelle Walensky, M.D.

LabCorp began using the CDC test last week and three other commercial laboratories are expected to soon, joining CDC’s Laboratory Response Network in performing the monkeypox test. CDC has reported over 860 U.S. monkeypox cases since May.
 

Related News Articles

Headline
The World Health Organization Aug. 14 declared a global health emergency due to the recent mpox outbreak in Africa, the second mpox declaration in two years.…
Headline
As summer Pride parades and other large gatherings approach, Americans at high risk for mpox (monkeypox) exposure should ensure they are fully vaccinated with…
Headline
The Food and Drug Administration Friday authorized for emergency use a molecular test to detect mpox (formerly known as monkeypox) at the point of care in…
Headline
The Food and Drug Administration Friday authorized for emergency use a real-time polymerase chain reaction test to detect mpox (formerly known as…
Headline
In a study of men under age 50 who were eligible to receive the JYNNEOS vaccine to prevent monkeypox (mpox) during the U.S. outbreak this year, unvaccinated…
Headline
The World Health Organization today recommended a new name for monkeypox that is intended to mitigate a rise in related racist and stigmatizing language…